End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
13,260
KRW
|
-0.67%
|
|
-1.78%
|
-18.95%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
457,200
|
373,200
|
382,800
|
514,800
|
412,800
|
392,640
|
Enterprise Value (EV)
1 |
674,417
|
572,543
|
545,259
|
729,683
|
593,925
|
471,572
|
P/E ratio
|
12
x
|
10.7
x
|
13.9
x
|
7.12
x
|
3.13
x
|
11.3
x
|
Yield
|
0.84%
|
0.96%
|
0.75%
|
0.93%
|
2.91%
|
1.53%
|
Capitalization / Revenue
|
0.58
x
|
0.46
x
|
0.47
x
|
0.52
x
|
0.31
x
|
0.38
x
|
EV / Revenue
|
0.86
x
|
0.7
x
|
0.68
x
|
0.73
x
|
0.45
x
|
0.46
x
|
EV / EBITDA
|
7.66
x
|
5.94
x
|
5.47
x
|
5.26
x
|
2.73
x
|
5.14
x
|
EV / FCF
|
34
x
|
15.1
x
|
8.83
x
|
-15.1
x
|
14.6
x
|
5.74
x
|
FCF Yield
|
2.94%
|
6.63%
|
11.3%
|
-6.64%
|
6.83%
|
17.4%
|
Price to Book
|
1.11
x
|
0.86
x
|
0.83
x
|
0.95
x
|
0.6
x
|
0.56
x
|
Nbr of stocks (in thousands)
|
24,000
|
24,000
|
24,000
|
24,000
|
24,000
|
24,000
|
Reference price
2 |
19,050
|
15,550
|
15,950
|
21,450
|
17,200
|
16,360
|
Announcement Date
|
3/8/19
|
3/5/20
|
3/19/21
|
3/3/22
|
2/24/23
|
2/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
788,738
|
814,340
|
807,768
|
998,190
|
1,329,509
|
1,029,975
|
EBITDA
1 |
88,062
|
96,394
|
99,646
|
138,624
|
217,851
|
91,763
|
EBIT
1 |
54,277
|
59,292
|
68,010
|
104,965
|
185,116
|
58,469
|
Operating Margin
|
6.88%
|
7.28%
|
8.42%
|
10.52%
|
13.92%
|
5.68%
|
Earnings before Tax (EBT)
1 |
46,333
|
48,322
|
51,157
|
101,184
|
181,100
|
49,494
|
Net income
1 |
38,084
|
34,754
|
27,453
|
72,273
|
131,932
|
34,847
|
Net margin
|
4.83%
|
4.27%
|
3.4%
|
7.24%
|
9.92%
|
3.38%
|
EPS
2 |
1,587
|
1,448
|
1,144
|
3,011
|
5,497
|
1,452
|
Free Cash Flow
1 |
19,834
|
37,957
|
61,759
|
-48,442
|
40,570
|
82,210
|
FCF margin
|
2.51%
|
4.66%
|
7.65%
|
-4.85%
|
3.05%
|
7.98%
|
FCF Conversion (EBITDA)
|
22.52%
|
39.38%
|
61.98%
|
-
|
18.62%
|
89.59%
|
FCF Conversion (Net income)
|
52.08%
|
109.22%
|
224.96%
|
-
|
30.75%
|
235.92%
|
Dividend per Share
2 |
160.0
|
150.0
|
120.0
|
200.0
|
500.0
|
250.0
|
Announcement Date
|
3/8/19
|
3/5/20
|
3/19/21
|
3/3/22
|
2/24/23
|
2/28/24
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2023 Q1
|
2023 Q3
|
---|
Net sales
|
260.1
|
283.5
|
338.4
|
342.7
|
350.7
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
30.05
|
36.58
|
57.2
|
54.26
|
49.31
|
-
|
-
|
Operating Margin
|
11.55%
|
12.91%
|
16.9%
|
15.83%
|
14.06%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
10.63
|
9.372
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
443.0
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/29/21
|
1/28/22
|
4/29/22
|
7/29/22
|
10/28/22
|
5/12/23
|
10/27/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
217,217
|
199,343
|
162,459
|
214,883
|
181,125
|
78,932
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.467
x
|
2.068
x
|
1.63
x
|
1.55
x
|
0.8314
x
|
0.8602
x
|
Free Cash Flow
1 |
19,834
|
37,957
|
61,759
|
-48,442
|
40,570
|
82,211
|
ROE (net income / shareholders' equity)
|
9.58%
|
8.27%
|
6.32%
|
14.1%
|
21.5%
|
5.02%
|
ROA (Net income/ Total Assets)
|
3.9%
|
4.19%
|
4.76%
|
6.54%
|
9.92%
|
3.17%
|
Assets
1 |
975,412
|
828,522
|
576,586
|
1,105,413
|
1,330,161
|
1,100,003
|
Book Value Per Share
2 |
17,163
|
17,983
|
19,113
|
22,636
|
28,443
|
29,400
|
Cash Flow per Share
2 |
2,638
|
2,631
|
3,033
|
4,073
|
4,365
|
4,108
|
Capex
1 |
28,929
|
30,322
|
21,227
|
24,296
|
45,073
|
38,392
|
Capex / Sales
|
3.67%
|
3.72%
|
2.63%
|
2.43%
|
3.39%
|
3.73%
|
Announcement Date
|
3/8/19
|
3/5/20
|
3/19/21
|
3/3/22
|
2/24/23
|
2/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.95% | 231M | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|